Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13) — A novel approach for the treatment of inflammatory bowel disease-Reference-Cited by-同舟云学术

Triggering endogenous immunosuppressive mechanisms by combined targeting of Dipeptidyl peptidase IV (DPIV/CD26) and Aminopeptidase N (APN/ CD13) — A novel approach for the treatment of inflammatory bowel disease

Published:2006-12 Issue:13-14 Volume:6 Page:1925-1934
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Bank Ute,Heimburg Anke,Helmuth Martin,Stefin Sofia,Lendeckel Uwe,Reinhold Dirk,Faust Jürgen,Fuchs Petra,Sens Bianca,Neubert Klaus,Täger Michael,Ansorge Siegfried

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference51 articles.

1. CD26: a surface protease involved in T-cell activation;Fleischer;Immunol Today,1994

2. Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review);Kähne;Int J Mol Med,1999

3. The role of dipeptidyl peptidase IV (DP IV) enzymatic activity in T cell activation and autoimmunity;Reinhold;Biol Chem,2002

4. CD26, let it cut or cut it down;De Meester;Immunol Today,1999

5. Dipeptidyl peptidase IV-like molecules: homologous proteins or homologous activities?;Sedo;Biochim Biophys Acta,2001

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Almost 50 Years of Monomeric Extracellular Ubiquitin (eUb);Pharmaceuticals;2024-01-31

2. Positive faecal immunochemical test predicts the onset of inflammatory bowel disease: A nationwide, propensity score-matched study;Frontiers in Immunology;2023-02-13

3. Central administration of human opiorphin alleviates dextran sodium sulfate-induced colitis in mice through activation of the endogenous opioid system;Frontiers in Pharmacology;2022-09-13

4. Characterization of Maladaptive Processes in Acute, Chronic and Remission Phases of Experimental Colitis in C57BL/6 Mice;Biomedicines;2022-08-05

5. Circulating Dipeptidyl Peptidase Activity Is a Potential Biomarker for Inflammatory Bowel Disease;Clinical and Translational Gastroenterology;2022-01